Efficacy of the Combination of Rituximab-Bendamustine As a Second-Line Treatment in Patients with Follicular Lymphoma Who Progress after Immunochemotherapy: a Phase II Trial of the Spanish Lymphoma Oncology Group

Antonio Rueda,Virginia Calvo,María Casanova, D. Rodríguez Abreu,David Aguiar,Marta Llanos,Ruth Álvarez,Natividad Martínez-Banaclocha,Jesús Alfaro,Cristina Quero,Ana Blasco,Luis de la Cruz‐Merino,J. Herrero,Francisco R. García-Arroyo,Mariano Provencio

Leukemia & lymphoma/Leukemia and lymphoma（2018）

引用 1|浏览0

暂无评分

摘要

Bendamustine is a drug widely used in the treatment of follicular lymphoma. Although it was initially approved as monotherapy in patients refractory to rituximab [1], better results were obtained w...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要